-transparent.png){kind=logo}
In a series of experiments involving approximately 500 animals, burned rats were administered the F(ab')2 fragment of antidonor IgG to study the survival of incompatible skin allografts. No prolongation was noted when treatment consisted of antidonor F(ab')2 fragment alone. This was true whether the fragment was raised against donor spleen cells of donor skin, whether the skin allograft was partial or full thickness and whether the systemic treatment of the recipients was preceded by a period of incubation of the graft in F(ab')2 fragment or not. Significant prolongation of survival was noted when the fragment was raised against both donor and recipient histocompatibility antigen and when the donor skin was incubated in steroids as well as in F(ab')2 fragment prior to grafting. Additional findings included the confirmation of prolonged allograft survival by increasing burn size and the prolongation of allograft survival by the presence of intact eschar.
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
September 1988,
Nuclear medicine communications,
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
January 1991,
International journal of immunopharmacology,
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
February 1990,
Cancer research,
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
April 2014,
Journal of pharmaceutical sciences,
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
March 1997,
Zhonghua fu chan ke za zhi,
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
November 1995,
European journal of immunology,
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
January 1982,
Arerugi = [Allergy],
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
October 2020,
Antiviral research,
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
April 1985,
Tissue antigens,
A C Raynor, and
B D Baird, and
D R Winters, and
M A Barnes, and
S T Yoakum, and
A G Leary, and
A M Munster
January 2018,
Human antibodies,
